349 related articles for article (PubMed ID: 8904164)
1. Cells and the activation of factor VII.
Rao LV; Rapaport SI
Haemostasis; 1996; 26 Suppl 1():1-5. PubMed ID: 8904164
[TBL] [Abstract][Full Text] [Related]
2. Studies of the activation of factor VII bound to tissue factor.
Rao LV; Williams T; Rapaport SI
Blood; 1996 May; 87(9):3738-48. PubMed ID: 8611699
[TBL] [Abstract][Full Text] [Related]
3. Dimerization of tissue factor supports solution-phase autoactivation of factor VII without influencing proteolytic activation of factor X.
Doñate F; Kelly CR; Ruf W; Edgington TS
Biochemistry; 2000 Sep; 39(37):11467-76. PubMed ID: 10985793
[TBL] [Abstract][Full Text] [Related]
4. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor-dependent autoactivation of human blood coagulation factor VII.
Yamamoto M; Nakagaki T; Kisiel W
J Biol Chem; 1992 Sep; 267(27):19089-94. PubMed ID: 1527033
[TBL] [Abstract][Full Text] [Related]
6. The lipoprotein-associated coagulation inhibitor.
Broze GJ; Girard TJ; Novotny WF
Prog Hemost Thromb; 1991; 10():243-68. PubMed ID: 2008533
[TBL] [Abstract][Full Text] [Related]
7. Influence of mutations in tissue factor on the fine specificity of macromolecular substrate activation.
Dittmar S; Ruf W; Edgington TS
Biochem J; 1997 Feb; 321 ( Pt 3)(Pt 3):787-93. PubMed ID: 9032467
[TBL] [Abstract][Full Text] [Related]
8. A candidate activation pathway for coagulation factor VII.
Misenheimer TM; Kumfer KT; Bates BE; Nettesheim ER; Schwartz BS
Biochem J; 2019 Oct; 476(19):2909-2926. PubMed ID: 31537632
[TBL] [Abstract][Full Text] [Related]
9. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis.
Mackman N; Tilley RE; Key NS
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1687-93. PubMed ID: 17556654
[TBL] [Abstract][Full Text] [Related]
10. Factor VIII activation by factor VIIa analog (V158D/E296V/M298Q) in tissue factor-independent mechanisms.
Ogiwara K; Nogami K; Shima M
Thromb Haemost; 2011 Oct; 106(4):665-74. PubMed ID: 21901232
[TBL] [Abstract][Full Text] [Related]
11. Factor VII and haemostasis.
Osterud B
Blood Coagul Fibrinolysis; 1990 Jun; 1(2):175-81. PubMed ID: 2130929
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor pathway.
McVey JH
Baillieres Clin Haematol; 1994 Sep; 7(3):469-84. PubMed ID: 7841596
[TBL] [Abstract][Full Text] [Related]
13. Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock.
Edgington TS; Mackman N; Fan ST; Ruf W
Nouv Rev Fr Hematol (1978); 1992; 34 Suppl():S15-27. PubMed ID: 1364116
[TBL] [Abstract][Full Text] [Related]
14. Raising the active site of factor VIIa above the membrane surface reduces its procoagulant activity but not factor VII autoactivation.
Waters EK; Yegneswaran S; Morrissey JH
J Biol Chem; 2006 Sep; 281(36):26062-8. PubMed ID: 16835245
[TBL] [Abstract][Full Text] [Related]
15. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway.
Sevinsky JR; Rao LV; Ruf W
J Cell Biol; 1996 Apr; 133(2):293-304. PubMed ID: 8609163
[TBL] [Abstract][Full Text] [Related]
16. Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII.
Nakagaki T; Foster DC; Berkner KL; Kisiel W
Biochemistry; 1991 Nov; 30(45):10819-24. PubMed ID: 1932002
[TBL] [Abstract][Full Text] [Related]
17. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
[TBL] [Abstract][Full Text] [Related]
18. Determination of the kinetic constants of tissue factor/factor VII/factor VIIA and antithrombin/heparin using surface plasmon resonance.
Björquist P; Boström S
Thromb Res; 1997 Feb; 85(3):225-36. PubMed ID: 9058497
[TBL] [Abstract][Full Text] [Related]
19. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa.
Callander NS; Rao LV; Nordfang O; Sandset PM; Warn-Cramer B; Rapaport SI
J Biol Chem; 1992 Jan; 267(2):876-82. PubMed ID: 1730676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
